lab_neu2024 Profile Banner
LAB-NEU Profile
LAB-NEU

@lab_neu2024

Followers
21
Following
401
Media
2
Statuses
36

Collaborative Neurology Advancement Laboratory @univaq; LAB-NEU is @Simona_Sacco, @RaffaeleOrnello, @mattfos89, @ChiaraRosx, @fededs00 and Agnese Onofri 🇮🇹🧠

L'Aquila, Italy
Joined January 2025
Don't wanna be here? Send us removal request.
@VitoriaAcarMD
Vitoria Acar
3 months
PACAP and CGRP = parallel, non-redundant roles in migraine. Could targeting multiple neuropeptides open the door to the next generation of therapies?
@JCephalalgia
Cephalalgia
3 months
Fresh insights into migraine biology 🧠✨ PACAP versus CGRP in migraine: From mouse models to clinical translation Presented today by Andrew F. Russo. Preclinical and clinical evidence shows PACAP and CGRP act as parallel, non-redundant migraine triggers. This suggests that a
0
2
5
@JCephalalgia
Cephalalgia
3 months
Cephalalgia Editorial Board Meeting during IHC2025 📚🧠 Reviewing past work and discussing exciting plans for the future. #ihc2025 #cephalalgia2025
0
5
12
@ESOstroke
European Stroke Org
3 months
ESO president @Simona_Sacco_ on the future of migraine management. #Neurology
@touchNEUROLOGY
touchNEUROLOGY
3 months
💡 Anti-CGRP therapies improve migraine control and adherence At #EAN2025, Prof. Simona Sacco (University of L’Aquila; President, European Stroke Organisation) shared insights on how anti-CGRP therapies are reshaping migraine care. These treatments show strong real-world
0
3
8
@Simona_Sacco_
Simona Sacco
4 months
“The ‘migraines epidemic’” signals a deeper problem in scientific writing. Careless use of AI tools like ChatGPT risks damaging the field. We must embrace innovation—but never at the expense of rigor and quality. 🔗 https://t.co/fbe4kZVGXe @JCephalalgia @ihs_official
Tweet card summary image
journals.sagepub.com
2
5
24
@JCephalalgia
Cephalalgia
6 months
🧪 New biomarker insights in migraine! A cross-sectional study of over 750 adults reveals: 🔹 Serum GFAP levels are modestly but significantly higher (+6.8%) in people with migraine vs. healthy controls. 🔹 Serum NfL levels? No difference found. 🔹 Results were independent of
0
5
22
@JCephalalgia
Cephalalgia
6 months
🌍🧠 Migraine Care Around the World – A New Collection in Cephalalgia Reports Migraine is a global burden—but access to care is far from equal. Our new topical collection spotlights the diverse challenges, innovations, and inequalities in migraine care across regions like Latin
0
1
7
@JCephalalgia
Cephalalgia
6 months
🚀 Join the Cephalalgia Reviewer Academy 2025/2026! 🚀 Are you a passionate professional about headaches? Boost your CV, gain peer review skills, and connect with experts! Who can apply? - Researchers and healthcare providers interested in headache. - No prior peer review
0
1
4
@lab_neu2024
LAB-NEU
6 months
Please to share our RCT just published in @JCephalalgia. One step forward to advance migraine care
@JCephalalgia
Cephalalgia
7 months
This research explores combining transcranial direct current stimulation (tDCS) with CGRP-targeting monoclonal antibodies to improve migraine treatment. tDCS as an adjunct: tDCS, applied alongside CGRP monoclonal antibodies, resulted in a significant reduction in migraine days
0
1
5
@Simona_Sacco_
Simona Sacco
7 months
It’s a double life - Stroke was my first love, headache my unexpected path—both have shaped who I am. Thank you The Lancet Neurology for telling my story. 🧠❤️ Simona Sacco: advancing knowledge in stroke and headache - The Lancet Neurology
7
10
89
@Simona_Sacco_
Simona Sacco
7 months
🎉 Congratulations to @fededs00, neurologist and PhD candidate at @univaq, for receiving the @ESOstroke Young Investigator Award! 👏🏻👏🏻👏🏻 A well-deserved recognition! Kudos to Raffaele Ornello, Matteo Foschi and Eleonora De Matteis, key members of the project team. So proud! 💪🏻🧠
2
4
43
@ESOstroke
European Stroke Org
7 months
🚀 #ESOC2025 kicked off strong with the ESO EAST Workshop, honoring Robert Mikulik & Veronika Svobodova for their achievments. Welcome to new Chairs Cristina Tiu 🇷🇴 & @AdamKobayashiMD 🇵🇱! #ESOEAST represents 250M+ Europeans since 2015—driving better stroke care together. 💙
1
5
29
@lab_neu2024
LAB-NEU
7 months
Mal di testa? Si comincia da piccoli: UnivAQ e SISC tra i banchi per la prevenzione https://t.co/eqLrTqEYje via @uan.univaq.it
0
0
0
@JCephalalgia
Cephalalgia
7 months
📢 Cephalalgia Fast-Track Review – Accelerate Your Publication Timeline Cephalalgia is pleased to offer a Fast-Track Review option for authors who require a more rapid editorial process. ✅ Editorial review within 72 hours by two experienced Reviewers ✅ Online publication
0
2
7
@Simona_Sacco_
Simona Sacco
8 months
Pleased to share the release of the new Migraine Guideline! A joint effort by the @SISCCefalee and @ihs_official Two versions are available on @JCephalalgia : • Summary version: https://t.co/kTUXlYkPNy • Extended version:
Tweet card summary image
journals.sagepub.com
We here present evidence-based guidelines for the pharmacological treatment of migraine. These guidelines, created by the Italian Society for the Study of Heada...
2
30
39
@ihs_official
International Headache Society
8 months
0
17
34
@almuftifawaz
Fawaz Al-Mufti, MD, FSVIN
8 months
@Simona_Sacco_ @JCephalalgia Congrats Simona!!
0
2
2
@lab_neu2024
LAB-NEU
8 months
📢#ASPERA study has been officialy presented at #ISA-stroke congress 2025 by @mattfos89 … ➡️DM us @mattfos89 @RaffaeleOrnello @Simona_Sacco_ @fededs00 to join the study @univaq @ISA_AII_Young
0
6
7
@CLOTStudy
Clot
9 months
🚨 Calling stroke & cardiology centres!!! We’re launching the CLOT International Collaboration — a multicentre international study on outcomes after IV thrombolysis and mechanical Thrombectomy in stroke patients undergoing cardiological procedures. 📷 Join us: DM or contact
0
3
3
@ESOstroke
European Stroke Org
9 months
Under the strong leadership of ESO President @Simona_Sacco_, today’s discussions were dynamic and forward-thinking. Engaged debates, insightful exchanges, and strategic brainstorming shaped the future of #strokescience and the ESO Society. Exciting times ahead—stay tuned!
0
18
57
@lab_neu2024
LAB-NEU
10 months
🔹 Why? Even “successful” responses often leave a significant impact on quality of life. 🔹 What’s proposed? A 4-tier outcome framework to redefine success in real-world practice. 🔹 The goal? Inspire clinicians, researchers & policymakers to push for better patient outcomes.
0
1
0